Tonix Pharmaceuticals Holding (TNXP) Earnings

Price: $17.82
Market Cap: $122.56M
Revenue (TTM): $10.09M
Net Income: $-130.04M
P/E Ratio: 0.00
EPS (TTM): $-5744.91

Earnings Dates

Tonix Pharmaceuticals Holding (TNXP) reports its earnings quarterly. Here are the key details:

Next Earnings Date
  • Date: May 12, 2025
  • Time of Day: Before Market Open
  • Estimated EPS: $-3.23
Last Earnings Report
  • Date: March 18, 2025
  • EPS: $-9.77
  • EPS Estimate: $-6.23

Tonix Pharmaceuticals Holding's next earnings report is scheduled for May 12, 2025.

In its last earnings report on March 18, 2025, Tonix Pharmaceuticals Holding reported earnings per share (EPS) of $-9.77, compared to an estimated EPS of $-6.23. The company reported revenue of $2.58M, compared to an estimated revenue of $3.20M.

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS

Earnings History

Date EPS EPS Estimate Revenue Revenue Estimate
March 18, 2025 $-9.77 $-6.23 $2.58M $3.20M
November 12, 2024 $-23.00 $-203.00 $2.82M $3.40M
August 16, 2024 $-1928.00 $-991.00 $2.21M $3.58M
April 01, 2024 $-2747.60 $-4984.03 $2.48M $3.80M
March 25, 2024 $-0.86 $-1.64 $3.78M $3.83M
November 09, 2023 $-5846.65 $-4760.38 $3.99M $5.13M
August 10, 2023 $-8562.30 $-8881.79 $- $-
May 08, 2023 $-10383.39 $-7987.22 $33.90M $-
March 13, 2023 $-11182.11 $-12579.87 $- $-
November 07, 2022 $-13777.96 $-14377.00 $- $-
August 08, 2022 $-24361.02 $-29153.36 $9.03M $-
May 09, 2022 $-31897.85 $-31897.85 $- $-
March 14, 2022 $-44656.98 $-44656.98 $- $-
November 08, 2021 $-31897.85 $-44656.98 $- $-
August 09, 2021 $-44656.98 $-44656.98 $- $-
May 10, 2021 $-44656.98 $-38277.41 $- $-
March 15, 2021 $-63795.69 $-57416.13 $2.91M $-

Annual Earnings

Annual Revenue

$10.09M

Fiscal Year 2024
Annual Net Income

$-130.04M

Fiscal Year 2024
Annual EPS

$-176.60

Fiscal Year 2024

Quarterly Earnings

Revenue

$2.58M

Quarter Ending December 31, 2024
Net Income

$-22.11M

Quarter Ending December 31, 2024
EPS

$-976.72

Quarter Ending December 31, 2024

Earnings Metrics

Earnings Yield

-535.47%

Year Ending December 31, 2024
P/E Ratio

-0.19

Year Ending December 31, 2024
Revenue Per Share

$13.71

Year Ending December 31, 2024
Earnings Yield (TTM)

-32238.54%

Trailing Twelve Months
P/E Ratio (TTM)

0.00

Trailing Twelve Months
Revenue Per Share (TTM)

$445.95

Trailing Twelve Months

Frequently Asked Questions

Tonix Pharmaceuticals Holding's next earnings date is scheduled for May 12, 2025. The earnings call is expected to take place before market open.

In its last earnings report on March 18, 2025, Tonix Pharmaceuticals Holding reported earnings per share (EPS) of $-9.77, compared to an estimated EPS of $-6.23. The company reported revenue of $2.58M, compared to an estimated revenue of $3.20M.

Tonix Pharmaceuticals Holding's current Price-to-Earnings (P/E) ratio is -0.19. The trailing twelve months (TTM) P/E ratio is 0.00. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.

For the fiscal year ending December 31, 2024, Tonix Pharmaceuticals Holding reported total revenue of $10.09M and net income of $-130.04M. This represents a net profit margin of -12.8825044581.

Tonix Pharmaceuticals Holding's earnings yield is -535.47%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.

Tonix Pharmaceuticals Holding's return on equity (ROE) is -93.18%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.

Tonix Pharmaceuticals Holding's gross profit margin is 23.07%. This indicates that for every dollar of revenue, the company retains $0.23 as gross profit after accounting for the cost of goods sold.

Sections